NHI Announces the Second Quarter 2026 Dividend

Rhea-AI Summary

National Health Investors (NYSE: NHI) declared a second quarter dividend of $0.92 per common share, payable on August 7, 2026 to holders of record as of June 30, 2026.

This is a scheduled cash distribution to shareholders with specified record and payment dates.

AI-generated analysis. Not financial advice.

Positive

• Dividend of $0.92 per share
• Clear record date of June 30, 2026 and payment date of August 7, 2026
• Continues payout policy supporting shareholder income

Negative

• No change to dividend amount disclosed; potential investor preference for increase not addressed

News Market Reaction – NHI

-3.46%

1 alert

-3.46% News Effect

On the day this news was published, NHI declined 3.46%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MURFREESBORO, Tenn., May 4, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today that it will pay its second quarter dividend of $0.92 per common share on August 7, 2026, to stockholders of record as of June 30, 2026.

About National Health Investors, Inc.
National Health Investors, Inc. (NYSE: NHI), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). The Company owns, leases, operates and finances the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments: Real Estate Investments and SHOP. The Company's investments in real estate properties include independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and hospitals. For more information, visit www.nhireit.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's expected future financial positions, results of operations, cash flows, funds from operations, dividend and dividend plans, financing opportunities and plans, capital market transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, acquisition integration, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations, continued performance improvements, ability to service and refinance debt obligations, ability to finance growth opportunities, and similar statements including, without limitation, those containing words such as "may", "will", "should", "believes", "anticipates", "expects", "intends", "estimates", "plans", "projects", "target", "likely" and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such risks and uncertainties include those risks and uncertainties which are described under the heading "Risk Factors" in Item 1A in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation to update any forward-looking statements, except as required by law, and these statements speak only as of the date on which they are made. Investors are urged to carefully review and consider the various disclosures made by the Company in its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information in the above referenced Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Copies of these filings are available at no cost on the SEC's web site at https://www.sec.gov or on the Company's website at www.nhireit.com.

Contact: Dana Hambly, Senior Vice President, Finance
Phone: (615) 890-9100

View original content to download multimedia:https://www.prnewswire.com/news-releases/nhi-announces-the-second-quarter-2026-dividend-302761526.html

SOURCE National Health Investors, Inc.

FAQ

What dividend did National Health Investors (NHI) announce for Q2 2026?

NHI announced a $0.92 per common share dividend for Q2 2026. According to National Health Investors, the dividend is payable on August 7, 2026 to shareholders of record as of June 30, 2026.

When is the NHI dividend record date and payment date for the second quarter 2026?

The record date is June 30, 2026 and the payment date is August 7, 2026. According to National Health Investors, shareholders on the record date will receive the declared $0.92 per share dividend on the payment date.

How much will NHI shareholders receive per share on August 7, 2026?

Shareholders will receive $0.92 per common share on August 7, 2026. According to National Health Investors, that payment applies to holders of record as of June 30, 2026 and is part of the Q2 dividend distribution.

Does the NHI announcement change the company dividend policy for 2026?

The announcement declares the Q2 dividend amount and dates but does not state a policy change. According to National Health Investors, this is a scheduled Q2 cash dividend of $0.92 per share with specified record and payment dates.

How can investors confirm they are eligible for the NHI Q2 2026 dividend?

Investors are eligible if they hold NHI common shares on June 30, 2026, the record date. According to National Health Investors, eligible holders as of that date will receive the $0.92 per share payment on August 7, 2026.